Terre Haute Chamber of Commerce supports new education board
Terre Haute -The Terre Haute Chamber of Commerce's Board of Directors is calling for a new board to oversee local schools.
The Chamber is endorsing Indiana Senate Bill 382.
According to the Chamber of Commerce, 'this bill would establish a local board of trusted leaders to oversee and guide the use of any county funds or property provided to the school corporation, an opportunity which is currently being explored.'
President/CEO, Kristin Craig, will testify in support of the bill at the Statehouse on Thursday, along with several other community leaders, including Vigo County Commissioner Chris Switzer, Mayor Brandon Sakbun, Vigo County School Board Member Amy Lore and Business Community Representative Andy Volkl, COO of Saturn Petcare.
'The Chamber, along with other key community stakeholders, are ready to support Senator Goode and his proactive and collaborative approach toward addressing the challenges facing Vigo County schools. By creating a trusted framework modeled on proven successes, this legislation ensures the community is prepared to act transparently and responsibly when and if opportunities for funding arise. Specifically, SB 382 establishes a governance structure that prioritizes accountability and aligns the resources available in the community with the most pressing needs,' said Craig.
Craig pointed out that this board ensures transparency, accountability and responsible resource management, reinforcing the community's trust in the process.
According to the Chamber of Commerce, the bill also requires that if the county transfers or gifts any unused funds or property to the school corporation, this local board will provide oversight to ensure those resources are used effectively and in the best interest of the community.
The Chamber will provide updates to its membership throughout the legislative session as this, and other relevant bills, progress through the legislature.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
CNX Announces Promotion of Alan Shepard to President
PITTSBURGH, June 12, 2025 /PRNewswire/ -- CNX Resources Corporation (NYSE: CNX) announces the promotion of Alan Shepard to the position of President in addition to his current role as Chief Financial Officer. "The opportunity set for the CNX team to continue to create per-share value for our owners and to positively transform our Appalachian communities has never been greater," said Nick Deiuliis, CNX CEO. "Since rejoining CNX in 2020, Alan has been integral to the development, communication, and execution of CNX's sustainable business model and the implementation of our capital allocation approach. Today's announcement recognizes both past achievements and our future expectations of his contributions to our continued success." Ian McGuire, Chairman of the Board of Directors of CNX added further: "This promotion reflects the collective confidence that the Board has in Alan's leadership as CNX moves forward. We look forward to continuing to work closely with him on long-term per-share value creation." The Board of Directors of CNX unanimously approved the promotion of Mr. Shepard to the position of President in addition to his current role as Chief Financial Officer. Mr. Shepard will continue to report to Mr. Deiuliis. About CNX ResourcesCNX Resources Corporation (NYSE: CNX) is unique. We are a premier, ultra-low carbon intensive natural gas development, production, midstream, and technology company centered in Appalachia, one of the most energy abundant regions in the world. With the benefit of a 161-year regional legacy, substantial asset base, leading core operational competencies, technology development and innovation, and astute capital allocation methodologies, we responsibly develop our resources and deploy free cash flow to create long-term per share value for our shareholders, employees, and the communities where we operate. As of December 31, 2024, CNX had 8.54 trillion cubic feet equivalent of proved natural gas reserves. The company is a member of the Standard & Poor's Midcap 400 Index. Additional information is available at View original content to download multimedia: SOURCE CNX Resources Corporation Sign in to access your portfolio
Business Insider
an hour ago
- Business Insider
Africa's richest man, Aliko Dangote steps down from one of his major establishments
Aliko Dangote will retire as Chairman of the Board of Dangote Sugar Refinery Plc on June 16, 2025, marking the end of two decades of leadership at one of Nigeria's most significant corporations. Aliko Dangote will retire as Chairman of Dangote Sugar Refinery Plc on June 16, 2025, concluding over two decades of leadership. Under his tenure, Dangote Sugar became a major entity in Nigeria's food industry, achieving significant expansions and projects. The Board acknowledged his contribution to advancing domestic sugar production through back integration initiatives in several Nigerian states. The declaration was made on Wednesday in a statement signed by Temitope Hassan, the company's secretary. 'In line with the principles of good corporate governance and succession planning, Dangote Sugar Refinery Plc hereby announces the retirement of our esteemed Chairman of the Board of Directors of the Company, Alhaji Aliko Dangote (GCON), effective June 16, 2025,' the statement read. Dangote, who founded the company in 2005 as one of the Dangote Group's primary subsidiaries, played a crucial role in developing the business into the dominant player in Nigeria's food sector. Dangote Sugar, under his leadership, completed large expansion projects and grew the company into a major pan-African enterprise. As per the statement, the corporation undertook important Backward Integration Projects in Adamawa, Taraba, and Nasarawa States under his direction in order to boost domestic sugar output and lessen reliance on imports. To facilitate a smooth transition, the Board has selected Arnold Ekpe, an independent non-executive director, as the next chairman. Ekpe has extensive expertise in the post, having held executive roles in many African banking and industrial enterprises, as seen in the Punch. His appointment represents continuity and stability as the corporation navigates its next chapter of expansion beyond Dangote's legacy. 'Following a rigorous selection and transition process, the Board is pleased to announce the appointment of Mr. Arnold Ekpe, Independent Non-Executive Director, as the new Chairman of Dangote Sugar Refinery Plc. effective 16th June 2025,' the statement reads. 'We welcome Mr. Ekpe to his new role and look forward to the next chapter in our Company's journey under his leadership. We also express our deep appreciation to Alhaji Aliko Dangote for his years of exemplary service and unwavering commitment to excellence,' it added,
Business Wire
4 hours ago
- Business Wire
Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva's flagship spin-off
GENEVA--(BUSINESS WIRE)--The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the Center, as Chief Business Officer and Co-founder of ABILITY Neurotech SA, a pioneering spin-off company translating breakthrough brain-computer interface (BCI) technology into clinical impact. Thrilled to share that Craig Cook has been named Chief Business Officer of Ability Neurotech SA, our flagship spin-off. A key force behind our venture-building model, Craig will now help Ability Neurotech shape the future of brain-computer interfaces. During his tenure at the Wyss Center, Craig Cook played a transformative role in establishing a strong business development framework and positioning the organization as a venture builder in neurotechnology. Under his leadership, six breakthrough technologies were successfully spun out into operational startup companies: Clee Medical SA, Brainscape Medical SA, Dataflight Ltd, BrainQuant SA, Aleos Bio SA, and ABILITY Neurotech SA. In parallel, Craig led the onboarding of aligned startups such as Dandelion Science Corp. and dEEGtal Insights SA, strengthening our AI and neurotech ecosystem. He also contributed to Series A investments in two Wyss-affiliated companies, Artiria Medical SA and Neurosoft Bioelectronics SA, bolstering our commitment to early-stage innovation. Now joining ABILITY Neurotech SA as Chief Business Officer and Co-founder, Craig will drive the company's fundraising strategy and operational growth. As the Wyss Center's flagship spin-off, ABILITY Neurotech is uniquely positioned to play an important role at the forefront of the brain-computer interface (BCI) revolution, ABILITY Neurotech offers a comprehensive end-to-end solution that spans neural signal capture, processing and seamless integration into clinical practice. 'Craig has been a catalyst for our mission,' said Prof. Erwin Böttinger, Director of the Wyss Center. 'His vision and energy have not only shaped our ecosystem but also brought our technologies closer to the market and to patients who need them. I look forward to seeing the continued impact of his work at ABILITY Neurotech.' Dr. Tracy Laabs, Head of Innovation and Strategic Partnerships at the Wyss Center, added: 'Craig's transition to lead one of our spin-offs is a clear example of the success of our model. It demonstrates how our translational approach—building and spinning out high-potential startups—can bring cutting-edge neurotechnologies closer to the clinic while empowering talented individuals to lead the next wave of innovation.' The Wyss Center extends its sincere gratitude to Craig Cook for his leadership and dedication and looks forward to continued collaboration with him in this exciting next chapter. About Wyss Geneva: Wyss Geneva is a non-profit advancing neurotechnologies to improve lives affected by neurological and mental health disorders. Based at Campus Biotech in Geneva, it develops AI, bioengineering, and neuroengineering solutions to restore neural function and enable precision therapies. Founded in 2014 with the support of philanthropist Hansjörg Wyss, it collaborates globally to drive innovation and clinical impact
